Crossmark

Clinical, toxicity and long-term neurocognitive outcomes of first-line intensive chemotherapy in infant medulloblastoma: a single-center cohort study following AIEOP recommendations

Crossref DOI link: https://doi.org/10.1007/s11060-025-05301-9

Published Online: 2025-10-29

Published Print: 2026-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Del Baldo, Giada https://orcid.org/0000-0003-3540-4331
Di Ruscio, Valentina https://orcid.org/0000-0002-9581-2751
Cacchione, Antonella https://orcid.org/0000-0003-4901-9952
Lo Sasso, Annalisa

Corvino, Ludovica

D’Orazio, Claudia https://orcid.org/0000-0002-0264-8519
De Salvo, Andrea https://orcid.org/0000-0002-8520-8008
Albino, Giulia https://orcid.org/0009-0001-6266-0966
Cipri, Selene https://orcid.org/0000-0002-8730-0094
Miele, Evelina https://orcid.org/0000-0002-4747-1032
Giovannoni, Isabella https://orcid.org/0000-0002-9980-6594
Rossi, Sabrina https://orcid.org/0000-0002-1477-8855
Colafati, Giovanna Stefania https://orcid.org/0000-0002-1142-4904
Vennarini, Sabina https://orcid.org/0000-0002-8712-8781
Carai, Andrea https://orcid.org/0000-0002-5203-7855
Mastronuzzi, Angela https://orcid.org/0000-0002-4408-2373
License Information

Text and Data Mining valid from 2025-10-29

Version of Record valid from 2025-10-29
More Information

Article History

Received: 13 August 2025

Accepted: 14 October 2025

First Online: 29 October 2025

Declarations

:

: The study was conducted by the Declaration of Helsinki and approved by the Institutional Review Board of Bambino Gesù Children’s. Code of Approval: RAP-2025-002.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below